Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer

被引:20
|
作者
Fan, Wen-Hua [1 ,2 ]
Xiao, Jian [3 ]
An, Xin [1 ,4 ]
Jiang, Wu [1 ,2 ]
Li, Li-Ren [1 ,2 ]
Gao, Yuan-Hong [1 ,5 ]
Chen, Gong [1 ,2 ]
Kong, Ling-Heng [1 ,2 ]
Lin, Jun-Zhong [1 ,2 ]
Wang, Jian-Ping [6 ]
Pan, Zhi-Zhong [1 ,2 ]
Ding, Pei-Rong [1 ,2 ]
机构
[1] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China
关键词
Rectal cancer; Neoadjuvant therapy; Chemoradiotherapy; Recurrence; TOTAL MESORECTAL EXCISION; PREOPERATIVE CHEMORADIOTHERAPY; LYMPH-NODES; PULMONARY METASTASES; CURATIVE RESECTION; POSTOPERATIVE CHEMORADIOTHERAPY; CLINICAL-SIGNIFICANCE; COLORECTAL-CANCER; SURGICAL SPECIMEN; CHEMORADIATION;
D O I
10.1007/s00432-017-2383-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Patients with locally advanced rectal cancer treated with neoadjuvant CRT and who achieved pCR from January 2004 to December 2012 were collected. The primary outcome measurement was the patterns of recurrence. Results Among 195 patients who achieved pCR, 18 developed recurrence. Furthermore, local recurrence occurred in 1.5% of patients (3/195), while distant metastases occurred in 7.7% of patients (15/195), which included 7 lung metastases, 1 liver metastasis, and 8 metastases in other locations. Conclusions Our study indicated that patients achieving pCR following neoadjuvant CRT have a favorable prognosis, with distant metastases predominating in all recurrences. Among patients with distant metastases, non-liver metastases were the predominant pattern.
引用
收藏
页码:1461 / 1467
页数:7
相关论文
共 50 条
  • [31] Predictive Factors of Pathologic Complete Response After Neoadjuvant Chemoradiation for Rectal Cancer
    Kalady, Matthew F.
    de Campos-Lobato, Luiz Felipe
    Stocchi, Luca
    Geisler, Daniel P.
    Dietz, David
    Lavery, Ian C.
    Fazio, Victor W.
    ANNALS OF SURGERY, 2009, 250 (04) : 582 - 589
  • [32] CEA - A Predictor for Pathologic Complete Response After Neoadjuvant Therapy for Rectal Cancer
    Wallin, Ulrik
    Rothenberger, David
    Lowry, Ann
    Luepker, Russell
    Mellgren, Anders
    DISEASES OF THE COLON & RECTUM, 2013, 56 (07) : 859 - 868
  • [33] Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer
    Blair, Alex B.
    Yin, Ling-Di
    Pu, Ning
    Yu, Jun
    Groot, Vincent P.
    Rozich, Noah S.
    Javed, Ammar A.
    Zheng, Lei
    Cameron, John L.
    Burkhart, Richard A.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    ANNALS OF SURGERY, 2021, 274 (01) : 162 - 169
  • [34] Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy
    Cui Jian
    Fang Hui
    Zhang Lin
    Wu YunLong
    Zhang HaiZeng
    慢性疾病与转化医学(英文), 2016, 2 (01) : 10 - 11-12-13-14-15-16
  • [35] Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
    Huang, Chun-Ming
    Huang, Ming-Yii
    Tsai, Hsiang-Lin
    Huang, Ching-Wen
    Su, Wei-Chih
    Chang, Tsung-Kun
    Chen, Yen-Cheng
    Li, Ching-Chun
    Wang, Jaw-Yuan
    CANCERS, 2021, 13 (18)
  • [36] Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
    Peng, Haihua
    Wang, Chengtao
    Xiao, Weiwei
    Lin, Xiaodan
    You, Kaiyun
    Dong, Jun
    Wang, Zhenyu
    Yu, Xiaobi
    Zeng, Zhifan
    Zhou, Tongchong
    Gao, Yuanhong
    Wen, Bixiu
    JOURNAL OF CANCER, 2018, 9 (15): : 2687 - 2692
  • [37] Prognostic impact of inflammation-based scores in esophageal cancer patients achieving pathologic complete response after neoadjuvant chemoradiotherapy followed by surgery
    Kang, J.
    Im, H-S.
    Kim, Y-H.
    Kim, H. R.
    Kim, J. H.
    Jung, H-Y.
    Lee, G-H.
    Song, H. J.
    Kim, D. H.
    Choi, K. D.
    Lee, J. H.
    Ahn, J. Y.
    Ryu, J-S.
    Cho, K-J.
    Kim, S-B.
    Park, S. R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival
    Donahue, James M.
    Nichols, Francis C.
    Li, Zhuo
    Schomas, David A.
    Allen, Mark S.
    Cassivi, Stephen D.
    Jatoi, Aminah
    Miller, Robert C.
    Wigle, Dennis A.
    Shen, K. Robert
    Deschamps, Claude
    ANNALS OF THORACIC SURGERY, 2009, 87 (02): : 392 - 399
  • [39] Risk factors of recurrence of rectal cancer after neoadjuvant chemoradiotherapy
    El Fadli, M.
    Yousra, B.
    Shawar Al Tamimi, N.
    Adjade, G.
    Essadi, I.
    Belbaraka, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S334 - S334
  • [40] QUANTIFYING THE BENEFIT OF A PATHOLOGIC COMPLETE RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER
    Scheer, Richard V.
    Fakiris, Achilles J.
    Johnstone, Peter A. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 996 - 1001